InsidersTradesSigma
Track the 질경이 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 질경이 has published 13 reports. Market capitalisation: €30.9bn. The latest transaction was filed on 28 May 2026 (Sale). Among the most active insiders: 최원석. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
13 of 13 declarations
질경이 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and marketing of health-related products.